HCIT Public Market Overview
Index Performance: EHR/RCM & Other HCIT (+3.5%) led on resilient recurring revenue, automation and AI adoption, while Pharma Services (-4%) and Benefits/Telehealth (-1%) lagged amid selective investor sentiment
EV / LTM Revenue: EHR/RCM leads at ~7.5x on recurring SaaS revenue and strong margins, followed by Pharma Services at ~4.7x; VBC remains lowest at ~0.45x due to thin margins and medical-cost exposure.
HCIT M&A Highlights
Selective Consolidation: Deal activity has cooled from Q3’25, but demand remains strong for scalable HCIT platforms with recurring revenue and clear ROI.
AI & Workflow Focus: Buyers continue targeting AI-enabled RCM, clinical workflows, interoperability and automation.
Platform Expansion: Strategic and PE buyers are using tuck-ins to broaden capabilities and build more integrated platforms.
Quality Over Volume: Higher financing costs and regulatory uncertainty are concentrating activity around profitable, differentiated assets.
HCIT Venture Funding Highlights
More Capital, Fewer Bets: Funding remains resilient despite fewer deals, reflecting larger checks into established market leaders.
Mega-Rounds Lead: $100M+ rounds accounted for 45% of H1’26 U.S. digital-health funding, highlighting investor preference for scaled businesses.
AI Is Expected: AI-enabled platforms continue to attract capital, but investors increasingly demand defensible data, distribution and measurable ROI.
Proof Over Growth: Clinical validation, commercial traction and sustainable unit economics are becoming key requirements for funding.
HCIT Public Market Valuation
Macro Theme
AI-Native EHR & Clinical Workflows: EHRs are evolving into AI-enabled platforms that embed documentation, decision support and workflow automation directly into care delivery.
Healthcare Workforce & Workflow Efficiency: Clinician shortages and administrative burden are accelerating demand for automation across documentation, scheduling, credentialing and onboarding.
Interoperability & Connected Data Ecosystems: FHIR, APIs and cloud infrastructure are enabling more seamless data exchange across EHRs, payers, providers and third-party applications.
Shift Toward Value-Based Care: Outcome-based reimbursement is increasing demand for technology that improves care quality, lowers costs and demonstrates measurable ROI.
RCM & Administrative Automation: Rising denials, prior-authorization requirements and administrative costs are driving adoption of AI-enabled billing, claims and payment automation.
Clinical AI & Imaging Transformation: AI is becoming increasingly embedded within diagnostic and clinical workflows, particularly across imaging and clinical decision support.
Cybersecurity & Infrastructure Resilience: Growing cyber threats and data breaches are making secure infrastructure, data protection and business continuity critical priorities for providers.
Regulatory & Reimbursement Modernization: Evolving digital-health frameworks are creating clearer regulatory and reimbursement pathways for software-based healthcare technologies.
ROI-Driven Technology Spending: HCIT spending is increasingly focused on solutions that deliver measurable productivity gains, cost savings, reimbursement capture and margin improvement.
Platform Consolidation & Vendor Rationalization: Health systems are favoring integrated platforms over fragmented point solutions, driving further consolidation and strategic M&A across HCIT.
Recent M&A and Venture Transactions
Earnings Update
Please see the detailed report below:
